12660sek
0,8 %
Date:2026-11-13Time:14:30:01Latest report:Q3-2026List:Mid CapTicker:BIOG B
Market Cap:12 757 msekEnterprise Value:12 238 msekNet Sales:1 654 msekEarnings:391,6 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:126,50
MA50:117,40
MA200:117,14
Price/MA200:7,9 %
RSI (14):63,4
Price/MA50:7,7 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.